Actavis sues FDA over generic Celebrex

Mon Apr 28, 2014 5:51pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 28 (Reuters) - Actavis Plc on Monday said it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc's blockbuster painkiller Celebrex.

The move follows a similar lawsuit announced Friday by Mylan Inc over generic drug marketing exclusivity for Celebrex. (Reporting by Susan Kelly in Chicago; Editing by Bernard Orr)